Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

4,221 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
A multi-center retrospective study on the efficacy and safety of regorafenib vs. regorafenib combined with PD-1 inhibitors as a second-line therapy in patients with advanced hepatocellular carcinoma.
Yan T, Huang C, Peng C, Duan X, Ji D, Duan Y, Zhang W, Zhao H, Gao K, Yang X, Zhang L, Cheng J, de Castria TB, Pocha C, Tsilimigras DI, Wu T, Su G, Li Y, Yu L, Lu Y. Yan T, et al. Ann Transl Med. 2023 Jan 31;11(2):109. doi: 10.21037/atm-22-6614. Ann Transl Med. 2023. PMID: 36819518 Free PMC article.
[Prognosis of hepatocellular carcinoma: a study of 832 cases].
Yan T, Zhao JJ, Bi XY, Zhao H, Huang Z, Li ZY, Zhou JG, Li Y, Li C, Cai JQ, Zhao P. Yan T, et al. Zhonghua Zhong Liu Za Zhi. 2013 Jan;35(1):54-8. doi: 10.3760/cma.j.issn.0253-3766.2013.01.012. Zhonghua Zhong Liu Za Zhi. 2013. PMID: 23648302 Chinese.
4,221 results